Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.
Identifieur interne : 002417 ( Main/Exploration ); précédent : 002416; suivant : 002418Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.
Auteurs : Motomu Hashimoto [Japon] ; Takao Fujii [Japon] ; Masahide Hamaguchi [Japon] ; Moritoshi Furu [Japon] ; Hiromu Ito [Japon] ; Chikashi Terao [Japon] ; Keiichi Yamamoto [Japon] ; Wataru Yamamoto [Japon] ; Takashi Matsuo [Japon] ; Masato Mori [Japon] ; Koichiro Ohmura [Japon] ; Hiroshi Kawabata [Japon] ; Tsuneyo Mimori [Japon]Source :
- PloS one [ 1932-6203 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Anticorps monoclonaux humanisés (immunologie), Anticorps monoclonaux humanisés (usage thérapeutique), Anémie (), Femelle, Humains, Hémoglobines (métabolisme), Immunothérapie, Jeune adulte, Mâle, Polyarthrite rhumatoïde (), Polyarthrite rhumatoïde (immunologie), Polyarthrite rhumatoïde (sang), Récepteurs à l'interleukine-6 (immunologie), Sujet âgé, Sujet âgé de 80 ans ou plus, Études de cohortes.
- MESH :
- immunologie : Anticorps monoclonaux humanisés, Polyarthrite rhumatoïde, Récepteurs à l'interleukine-6.
- métabolisme : Hémoglobines.
- sang : Polyarthrite rhumatoïde.
- usage thérapeutique : Anticorps monoclonaux humanisés.
- Adulte, Adulte d'âge moyen, Anémie, Femelle, Humains, Immunothérapie, Jeune adulte, Mâle, Polyarthrite rhumatoïde, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de cohortes.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Anemia (complications), Anemia (therapy), Antibodies, Monoclonal, Humanized (immunology), Antibodies, Monoclonal, Humanized (therapeutic use), Arthritis, Rheumatoid (blood), Arthritis, Rheumatoid (complications), Arthritis, Rheumatoid (immunology), Arthritis, Rheumatoid (therapy), Cohort Studies, Female, Hemoglobins (metabolism), Humans, Immunotherapy, Male, Middle Aged, Receptors, Interleukin-6 (immunology), Young Adult.
- MESH :
- chemical , immunology : Antibodies, Monoclonal, Humanized, Receptors, Interleukin-6.
- blood : Arthritis, Rheumatoid.
- complications : Anemia, Arthritis, Rheumatoid.
- immunology : Arthritis, Rheumatoid.
- chemical , metabolism : Hemoglobins.
- chemical , therapeutic use : Antibodies, Monoclonal, Humanized.
- therapy : Anemia, Arthritis, Rheumatoid.
- Adult, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Immunotherapy, Male, Middle Aged, Young Adult.
Abstract
To compare the effect of tocilizumab (TCZ) with other biologic therapies in improving anemia of rheumatoid arthritis (RA) patients.
DOI: 10.1371/journal.pone.0098202
PubMed: 24878740
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001394
- to stream PubMed, to step Curation: 001394
- to stream PubMed, to step Checkpoint: 001345
- to stream Ncbi, to step Merge: 000B34
- to stream Ncbi, to step Curation: 000B34
- to stream Ncbi, to step Checkpoint: 000B34
- to stream Main, to step Merge: 002419
- to stream Main, to step Curation: 002417
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.</title><author><name sortKey="Hashimoto, Motomu" sort="Hashimoto, Motomu" uniqKey="Hashimoto M" first="Motomu" last="Hashimoto">Motomu Hashimoto</name><affiliation wicri:level="4"><nlm:affiliation>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Fujii, Takao" sort="Fujii, Takao" uniqKey="Fujii T" first="Takao" last="Fujii">Takao Fujii</name><affiliation wicri:level="4"><nlm:affiliation>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Hamaguchi, Masahide" sort="Hamaguchi, Masahide" uniqKey="Hamaguchi M" first="Masahide" last="Hamaguchi">Masahide Hamaguchi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author><author><name sortKey="Furu, Moritoshi" sort="Furu, Moritoshi" uniqKey="Furu M" first="Moritoshi" last="Furu">Moritoshi Furu</name><affiliation wicri:level="4"><nlm:affiliation>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Ito, Hiromu" sort="Ito, Hiromu" uniqKey="Ito H" first="Hiromu" last="Ito">Hiromu Ito</name><affiliation wicri:level="4"><nlm:affiliation>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Terao, Chikashi" sort="Terao, Chikashi" uniqKey="Terao C" first="Chikashi" last="Terao">Chikashi Terao</name><affiliation wicri:level="4"><nlm:affiliation>Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Yamamoto, Keiichi" sort="Yamamoto, Keiichi" uniqKey="Yamamoto K" first="Keiichi" last="Yamamoto">Keiichi Yamamoto</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical and Epidemiological Database, Department of Information Governance, National Cerebral and Cardiovascular Center, Osaka, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Clinical and Epidemiological Database, Department of Information Governance, National Cerebral and Cardiovascular Center, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author><author><name sortKey="Yamamoto, Wataru" sort="Yamamoto, Wataru" uniqKey="Yamamoto W" first="Wataru" last="Yamamoto">Wataru Yamamoto</name><affiliation wicri:level="4"><nlm:affiliation>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Health Information Management, Kurashiki Sweet Hospital, Kurashiki, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Health Information Management, Kurashiki Sweet Hospital, Kurashiki</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Matsuo, Takashi" sort="Matsuo, Takashi" uniqKey="Matsuo T" first="Takashi" last="Matsuo">Takashi Matsuo</name><affiliation wicri:level="4"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Mori, Masato" sort="Mori, Masato" uniqKey="Mori M" first="Masato" last="Mori">Masato Mori</name><affiliation wicri:level="4"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Ohmura, Koichiro" sort="Ohmura, Koichiro" uniqKey="Ohmura K" first="Koichiro" last="Ohmura">Koichiro Ohmura</name><affiliation wicri:level="4"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Kawabata, Hiroshi" sort="Kawabata, Hiroshi" uniqKey="Kawabata H" first="Hiroshi" last="Kawabata">Hiroshi Kawabata</name><affiliation wicri:level="4"><nlm:affiliation>Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Mimori, Tsuneyo" sort="Mimori, Tsuneyo" uniqKey="Mimori T" first="Tsuneyo" last="Mimori">Tsuneyo Mimori</name><affiliation wicri:level="4"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24878740</idno><idno type="pmid">24878740</idno><idno type="doi">10.1371/journal.pone.0098202</idno><idno type="wicri:Area/PubMed/Corpus">001394</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001394</idno><idno type="wicri:Area/PubMed/Curation">001394</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001394</idno><idno type="wicri:Area/PubMed/Checkpoint">001345</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001345</idno><idno type="wicri:Area/Ncbi/Merge">000B34</idno><idno type="wicri:Area/Ncbi/Curation">000B34</idno><idno type="wicri:Area/Ncbi/Checkpoint">000B34</idno><idno type="wicri:Area/Main/Merge">002419</idno><idno type="wicri:Area/Main/Curation">002417</idno><idno type="wicri:Area/Main/Exploration">002417</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.</title><author><name sortKey="Hashimoto, Motomu" sort="Hashimoto, Motomu" uniqKey="Hashimoto M" first="Motomu" last="Hashimoto">Motomu Hashimoto</name><affiliation wicri:level="4"><nlm:affiliation>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Fujii, Takao" sort="Fujii, Takao" uniqKey="Fujii T" first="Takao" last="Fujii">Takao Fujii</name><affiliation wicri:level="4"><nlm:affiliation>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Hamaguchi, Masahide" sort="Hamaguchi, Masahide" uniqKey="Hamaguchi M" first="Masahide" last="Hamaguchi">Masahide Hamaguchi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author><author><name sortKey="Furu, Moritoshi" sort="Furu, Moritoshi" uniqKey="Furu M" first="Moritoshi" last="Furu">Moritoshi Furu</name><affiliation wicri:level="4"><nlm:affiliation>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Ito, Hiromu" sort="Ito, Hiromu" uniqKey="Ito H" first="Hiromu" last="Ito">Hiromu Ito</name><affiliation wicri:level="4"><nlm:affiliation>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Terao, Chikashi" sort="Terao, Chikashi" uniqKey="Terao C" first="Chikashi" last="Terao">Chikashi Terao</name><affiliation wicri:level="4"><nlm:affiliation>Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Yamamoto, Keiichi" sort="Yamamoto, Keiichi" uniqKey="Yamamoto K" first="Keiichi" last="Yamamoto">Keiichi Yamamoto</name><affiliation wicri:level="1"><nlm:affiliation>Division of Clinical and Epidemiological Database, Department of Information Governance, National Cerebral and Cardiovascular Center, Osaka, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Division of Clinical and Epidemiological Database, Department of Information Governance, National Cerebral and Cardiovascular Center, Osaka</wicri:regionArea><wicri:noRegion>Osaka</wicri:noRegion></affiliation></author><author><name sortKey="Yamamoto, Wataru" sort="Yamamoto, Wataru" uniqKey="Yamamoto W" first="Wataru" last="Yamamoto">Wataru Yamamoto</name><affiliation wicri:level="4"><nlm:affiliation>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Health Information Management, Kurashiki Sweet Hospital, Kurashiki, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Health Information Management, Kurashiki Sweet Hospital, Kurashiki</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Matsuo, Takashi" sort="Matsuo, Takashi" uniqKey="Matsuo T" first="Takashi" last="Matsuo">Takashi Matsuo</name><affiliation wicri:level="4"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Mori, Masato" sort="Mori, Masato" uniqKey="Mori M" first="Masato" last="Mori">Masato Mori</name><affiliation wicri:level="4"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Ohmura, Koichiro" sort="Ohmura, Koichiro" uniqKey="Ohmura K" first="Koichiro" last="Ohmura">Koichiro Ohmura</name><affiliation wicri:level="4"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Kawabata, Hiroshi" sort="Kawabata, Hiroshi" uniqKey="Kawabata H" first="Hiroshi" last="Kawabata">Hiroshi Kawabata</name><affiliation wicri:level="4"><nlm:affiliation>Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author><author><name sortKey="Mimori, Tsuneyo" sort="Mimori, Tsuneyo" uniqKey="Mimori T" first="Tsuneyo" last="Mimori">Tsuneyo Mimori</name><affiliation wicri:level="4"><nlm:affiliation>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto</wicri:regionArea><orgName type="university">Université de Kyoto</orgName><placeName><settlement type="city">Kyoto</settlement><region type="prefecture">Région du Kansai</region></placeName></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Anemia (complications)</term><term>Anemia (therapy)</term><term>Antibodies, Monoclonal, Humanized (immunology)</term><term>Antibodies, Monoclonal, Humanized (therapeutic use)</term><term>Arthritis, Rheumatoid (blood)</term><term>Arthritis, Rheumatoid (complications)</term><term>Arthritis, Rheumatoid (immunology)</term><term>Arthritis, Rheumatoid (therapy)</term><term>Cohort Studies</term><term>Female</term><term>Hemoglobins (metabolism)</term><term>Humans</term><term>Immunotherapy</term><term>Male</term><term>Middle Aged</term><term>Receptors, Interleukin-6 (immunology)</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anticorps monoclonaux humanisés (immunologie)</term><term>Anticorps monoclonaux humanisés (usage thérapeutique)</term><term>Anémie ()</term><term>Femelle</term><term>Humains</term><term>Hémoglobines (métabolisme)</term><term>Immunothérapie</term><term>Jeune adulte</term><term>Mâle</term><term>Polyarthrite rhumatoïde ()</term><term>Polyarthrite rhumatoïde (immunologie)</term><term>Polyarthrite rhumatoïde (sang)</term><term>Récepteurs à l'interleukine-6 (immunologie)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de cohortes</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term><term>Receptors, Interleukin-6</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Anemia</term><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps monoclonaux humanisés</term><term>Polyarthrite rhumatoïde</term><term>Récepteurs à l'interleukine-6</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Hemoglobins</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Hémoglobines</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Polyarthrite rhumatoïde</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Anemia</term><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticorps monoclonaux humanisés</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Cohort Studies</term><term>Female</term><term>Humans</term><term>Immunotherapy</term><term>Male</term><term>Middle Aged</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Anémie</term><term>Femelle</term><term>Humains</term><term>Immunothérapie</term><term>Jeune adulte</term><term>Mâle</term><term>Polyarthrite rhumatoïde</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de cohortes</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To compare the effect of tocilizumab (TCZ) with other biologic therapies in improving anemia of rheumatoid arthritis (RA) patients.</div></front></TEI><affiliations><list><country><li>Japon</li></country><region><li>Région du Kansai</li></region><settlement><li>Kyoto</li></settlement><orgName><li>Université de Kyoto</li></orgName></list><tree><country name="Japon"><region name="Région du Kansai"><name sortKey="Hashimoto, Motomu" sort="Hashimoto, Motomu" uniqKey="Hashimoto M" first="Motomu" last="Hashimoto">Motomu Hashimoto</name></region><name sortKey="Fujii, Takao" sort="Fujii, Takao" uniqKey="Fujii T" first="Takao" last="Fujii">Takao Fujii</name><name sortKey="Furu, Moritoshi" sort="Furu, Moritoshi" uniqKey="Furu M" first="Moritoshi" last="Furu">Moritoshi Furu</name><name sortKey="Hamaguchi, Masahide" sort="Hamaguchi, Masahide" uniqKey="Hamaguchi M" first="Masahide" last="Hamaguchi">Masahide Hamaguchi</name><name sortKey="Ito, Hiromu" sort="Ito, Hiromu" uniqKey="Ito H" first="Hiromu" last="Ito">Hiromu Ito</name><name sortKey="Kawabata, Hiroshi" sort="Kawabata, Hiroshi" uniqKey="Kawabata H" first="Hiroshi" last="Kawabata">Hiroshi Kawabata</name><name sortKey="Matsuo, Takashi" sort="Matsuo, Takashi" uniqKey="Matsuo T" first="Takashi" last="Matsuo">Takashi Matsuo</name><name sortKey="Mimori, Tsuneyo" sort="Mimori, Tsuneyo" uniqKey="Mimori T" first="Tsuneyo" last="Mimori">Tsuneyo Mimori</name><name sortKey="Mori, Masato" sort="Mori, Masato" uniqKey="Mori M" first="Masato" last="Mori">Masato Mori</name><name sortKey="Ohmura, Koichiro" sort="Ohmura, Koichiro" uniqKey="Ohmura K" first="Koichiro" last="Ohmura">Koichiro Ohmura</name><name sortKey="Terao, Chikashi" sort="Terao, Chikashi" uniqKey="Terao C" first="Chikashi" last="Terao">Chikashi Terao</name><name sortKey="Yamamoto, Keiichi" sort="Yamamoto, Keiichi" uniqKey="Yamamoto K" first="Keiichi" last="Yamamoto">Keiichi Yamamoto</name><name sortKey="Yamamoto, Wataru" sort="Yamamoto, Wataru" uniqKey="Yamamoto W" first="Wataru" last="Yamamoto">Wataru Yamamoto</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002417 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002417 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24878740
|texte= Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24878740" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a TocilizumabV1
| This area was generated with Dilib version V0.6.34. |  |